Results 191 to 200 of about 22,026 (263)

Concomitant Use of DPP-4 Inhibitors May Prevent the Development of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Cohort Study. [PDF]

Clin Transl Sci
Koura Y, Mine K, Fujita S, Kawashiri T, Mori Y, Ueda M, Kaneko R, Hirota T, Uchida M, Kobayashi D.   +9 more
europepmc   +1 more source

Association of <i>DPP4</i> Gene Variants with Classic and DPP4 Inhibitor-Associated Bullous Pemphigoid. [PDF]

Int J Mol Sci
Achilla C, Foutsitzidou C, Meltzanidou P, Patsatsi A, Lazaridou E, Tzatzagou G, Lambropoulos A, Chatzikyriakidou A.   +7 more
europepmc   +1 more source

SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation. [PDF]

PLoS Med
Shao SC, Tsai DH, Chuang AT, Liu KH, Lai EC.   +4 more
europepmc   +1 more source

Peptides From Adzuki Bean and Soybean Improved Insulin-AKT Signaling-Related Pathways in Healthy and Insulin-Resistant States in Human Liver Cells. [PDF]

Mol Nutr Food Res
Kwan SH, Gonzalez de Mejia E.
europepmc   +1 more source

Combined effects of physical activity and diabetes medications on glycemic control: a real-world data study. [PDF]

Sci Rep
Yamamoto K, Kai R, Inano A, Mizuno M.
europepmc   +1 more source

Subtype-Specific Causal Effects of Antidiabetic Drug Targets on Ovarian Cancer: Mendelian Randomization and Colocalization Evidence. [PDF]

Int J Womens Health
Tang E, Zeng J, Shi X, Wang Y, Sun Y, Wu L.   +5 more
europepmc   +1 more source

Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus. [PDF]

Pharmacoepidemiol Drug Saf
Aloke C, Adelusi OA, Onisuru OO, Iwuchukwu EA, Achilonu I.   +4 more
europepmc   +1 more source

Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies. [PDF]

Diabetes Care
McCormick N, Burrack N, Yokose C, Lu N, Wexler DJ, Rai SK, Challener GJ, Aviña-Zubieta JA, McCoy RG, Abuhasira R, Choi HK.   +10 more
europepmc   +1 more source

Edible Yellow Mealworm-Derived Antidiabetic Peptides: Dual Modulation of α-Glucosidase and Dipeptidyl-Peptidase IV Inhibition Revealed by Integrated Proteomics, Bioassays, and Molecular Docking Analysis. [PDF]

Foods
Zhu Y, Zhou E, Tang Y, Li Q, Wu L.
europepmc   +1 more source

Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis. [PDF]

Clin Mol Hepatol
Choi J, Fulop D, Nguyen VH, Przybyszewski E, Song J, Carroll A, Michta M, Almazan E, Simon TG, Chung RT.   +9 more
europepmc   +1 more source